Ani Pharmaceuticals (ANIP) Change in Taxes (2014 - 2026)

Ani Pharmaceuticals has disclosed Change in Taxes across 13 years of filings, most recently posting $14.1 million for Q1 2026.

• Change in Taxes for Q1 2026 came in at $14.1 million, up 89.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.9 million (down 418.84% YoY), and the FY2025 annual result was -$15.5 million, down 997.6% from the prior year.
• Change in Taxes came in at $14.1 million for Q1 2026 at Ani Pharmaceuticals, up from $472000.0 in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $14.1 million in Q1 2026 to a low of -$14.3 million in Q2 2024.
• The 5-year median for Change in Taxes is $92000.0 (2023), against an average of $527764.7.
• Across the five-year window, Change in Taxes surged 15538.78% in 2023 and slumped 3942.21% in 2024, its largest moves.
• Ani Pharmaceuticals' Change in Taxes stood at -$49000.0 in 2022, then soared by 15538.78% to $7.6 million in 2023, then jumped by 69.9% to $12.9 million in 2024, then slumped by 96.33% to $472000.0 in 2025, then surged by 2884.53% to $14.1 million in 2026.
• The last three Change in Taxes figures came in at $14.1 million (Q1 2026), $472000.0 (Q4 2025), and -$12.5 million (Q3 2025), per Business Quant data.